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0.02, p0.042), low vision in both eyes (difference:0.02, p0.041), and blindness
in both eyes (difference: 0.10, p0.0001) had lower EQ-5D score than those with-
out visual impairment. Singapore Indians with low vision in both eyes (difference:
0.03, p0.0081), low vision in one eye and blindness in the other eye (difference:
0.09, p0.0001), and blindness in both eyes (difference: 0.16, p0.0004) had
lower EQ-5D score than those without visual impairment. After adjusted for age,
gender and co-morbidities, none of the 5 eye conditions was associated with re-
duction in EQ-5D scores inMalays or Indians, except that Indianswith cataract had
lower EQ-5D scores than those without cataract (difference: 0.02, p0.0431).
CONCLUSIONS: Health burden is associated with visual impairment, but not with
the presence of the eye conditions. Vision problems pose more health burden to
Indians than Malays in Singapore.
URINARY/KIDNEY DISORDERS - Clinical Outcomes Studies
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OBJECTIVES: To evaluate the effect of aqueous extract of Boswellia serrata Roxb
oleo gumon urinary electrolytes, pH and diuresis in normal albino rats.METHODS:
Oleo gumweighing 500g was soaked in hot boiling water (1L) at room temperature
for 3 days with occasional shaking. Filtrate was evaporated on rotary evaporator
under reduced pressure (760 mmHg) to a thick, semi-solid pasty mass of dark
drown color that was completely solubilized in both distilled water and normal
saline for in-vitro and in-vivo experimentation. Phytochemical analysis was car-
ried out for alkaloids, saponins, anthraquinones, flavanoids and tannins. For in-
vivo activity, five groups of with six animals in each were administered normal
saline (10ml/Kg, i.p.), Furosemide (10mg/kg) and crude extracts of Boswellia sarrata
(10, 30 and 50mg/kg of body weight), respectively. Toxicological effect of plant was
undertaken in rats at a dose of 3000mg/kg. Data was expressed asmean SEM and
analyzed using Graph Pad Prism (Graph PAD, San Diego, USA). Student t-test was
applied for data analysis. p values 0.05 were considered significant. RESULTS:
Phytochemical screening of Boswellia serrata Roxb confirmed the presence of sa-
ponins and flavonoids. Furosemide induced significant diuresis and electrolytes
(Na&K) excretionwhile plant extracts increased urinary output and electrolytes
excretion in a dose-dependentmanner. Diuretic index of test groupswere1.36, 2.06
and 2.9, respectively while, Lipschitz value also confirmed diuretic activity in dose
dependent manner. Urinary pH remained unchanged during the course of the
study whereas, no lethality was observed at the dose of 3000mg/kg.
CONCLUSIONS: Aqueous Boswellia serrata oleo gum extracts administered partic-
ularly at the dose of 50mg/kg significantly induced water and electrolytes with no
signs of toxicity.
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OBJECTIVES: To assess economic burden associated with hemodialysis (HD) and
continuous ambulatory peritoneal dialysis (CAPD) among patients with end-stage
renal disease (ESRD) and treated in a tertiary hospital in China. METHODS: From
Sept 2004 to Jan 2005, adult patients on HD or CAPD for at least 6 months were
recruited. Resource utilization and costs were collected by medical records review
and patient survey. The economic burden was divided into direct costs including
medical (dialysis, drugs, lab, and inpatient) and nonmedical (transportation, hired
caregivers, and special nutritional products) and indirect costs due to productivity
loss (human capital approach). The annualized costs expressed in 2010 Yuan(¥)
were analyzed using Wilcoxon test and General Linear Model with gamma distri-
bution and log link. RESULTS: Eighty-six patients [50 on CAPD and 36 on standard
HD (3x4-hour weekly)] were included for the analysis, with 55% male and a mean
age of 57.715.6 years. No differences were found in age, sex, education, payment
method, income, originating disease, haemoglobin level, and dialysis time be-
tween HD and CAPD. Mean(SD)/Median of annual medical expenses were
¥91,476(42,935)/¥82,478 for HD and ¥68,898(11,698)/¥68,191 for CAPD (p0.0001);
nonmedical direct expenses were ¥5,883(4,256)/¥4,780 for HD and ¥3,041(3,835)/
¥1,300 for CAPD (p0.0001). No differencewas found in indirect costs [¥3,167 (6,992)
for HD and ¥5,064 (8,354) for CAPD (p0.3)]. Total annual costs were
¥100,403(44,419)/¥90,262 for HD and ¥79,859(22,210)/¥77,681 for CAPD (p0.001).
Controlling for key factors/covariates, HD patients incurred 16% higher total cost
compared to CAPD patients (p0.01). Patients with younger age (p0.005), public
health insurance (p0.0001), or originating disease of diabetes (p0.03) incurred
higher total costs compared to their counterparts, respectively. CONCLUSIONS:
Patients received HD incurred more direct costs compared to patients undergoing
CAPD. The findings of this study may help understand the disease burden and
establish cost-effective treatment modalities in ESRD from Chinese societal per-
spective.
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OBJECTIVES: To evaluate the annual health expenditure (AHE) in patients with
neurogenic detrusor overactivity (NDO) after spinal cord injury (SCI). METHODS:
Data containing 2 million randomly sampled individuals from the National Health
Insurance Research Database (NHIRD) in Taiwan were used. Patients with emer-
gency department visits or hospitalizations for SCI defined by ICD-9 codes 806.X
and 952.X between 2006 and 2008 were retrieved. NDOwas defined by: 1) diagnosis
defined by ICD-9 codes 596.5 and 788.3 (excluding 596.53, paralysis of bladder); 2)
pharmacological treatment for neurogenic voiding dysfunction and urinary symp-
toms such as alpha blockers, antimuscarinic agents, and cholinergic agents; and 3)
procedures such as indwelling or intermittent catheterization defined byNHI codes
47,013C and 47,014C. All patients were followed for one year. The total AHE, as well
as three subcategories, hospital, outpatient, and pharmacological treatment re-
lated cost were calculated respectively. Covariates including patient’s demograph-
ics, hospital length of stay, concomitant medications, and comorbid conditions
were considered in the final linear regression to compare the AHE between NDO
and non-NDO group. RESULTS: A total of 941 eligible individuals with SCI were
identified from 2006 to 2008, of whom 165 (17.5%) were NDO cases with amean age
of 54 and consisting of 64%male. The total AHEwas 494,325 (499,259) and 108,529
(147,287) N.T. dollars inNDO and non-NDO group, respectively. After adjusting by
regression model, the total AHE was higher in NDO (364,611; SE21,082;
p0.001) than non-NDO group. Higher AHE was also shown in NDO in each sub-
category when comparing with non-NDO. CONCLUSIONS: A significant impact on
the financial burden of NDO was shown in this study. Higher AHE associated with
NDOmay also reflective of the higher severity of SCI or other comorbid conditions.
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OBJECTIVES:To estimate the total economic burden of both peritoneal dialysis and
renal anemia treatment in China. METHODS: Eight medical centers with regular
follow-up system for peritoneal dialysis patients in 6 provinces were selected for
prospective observation research. Inclusion and exclusion criteria were set down
before the study through the discussion with clinical experts. Patients had been
recruited in the study since July of 2011. Patient baseline characteristics, treatment
and expenditure for both outpatient and inpatient during 3-months follow-up du-
ration were recorded. Direct medical costs included fee for registration and ser-
vices, medical examination, drugs andmedical consumable materials. Direct non-
medical costs included transportation fee and nursing fee. Off-work days were
collected to estimate indirect costs.RESULTS:A total of 149 patientswith records of
703 outpatient visits and 19 inpatient stays were collected. Mean age of patients is
50.9with averagely 3.47 years of peritoneal dialysis treatment and 3.35 years of EPO
treatment. The average frequencywas 1.41 visits inmedical centers permonth and
1.23 visits in community health centers. The average cost of EPO was CNY1,518
(US$241) per month with average dosage of 16443IU. Total economic burden per
peritoneal dialysis patient was CNY9,756 (US$1,549) per month, including
CNY9,163 (US$1,454) for direct medical costs, CNY210 (US$33) for direct non-med-
ical costs and CNY383 (US$61) for indirect costs. The share of total economic bur-
den related to GDP per capita ranged from 1.3 times to 6.4 times in 6 sampling
provinces. CONCLUSIONS: The total economic burden of both peritoneal dialysis
and renal anemia treatment seems relatively high, which needs more attention
from the government and society.
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OBJECTIVES: This study evaluated the clinical and economic impacts of clinical
pharmacy education (CPE) on infection management among patients with chronic
kidney disease (CKD) stage 4 and 5 in Haji Adam Malik (HAM) hospital, Indonesia.
METHODS: A quasi-experimental economic evaluation comparing CPE impact on
six-months CKD mortality was conducted based on payer perspective. The exper-
imental group (n63) received care by health care providers that were given CPE on
DRPs and dose adjustment. The control group (n80) was based on the historical
cohort of patients that received care before the CPE. Measure of clinical outcome
applied in this study was number of lives saved/100 patients treated. Cost-effec-
tiveness (CE) ratios for stage 4 and 5 CKD patients without CPE and with CPE,
incremental cost effectiveness ratios (ICERs) for stage 4 and 5 CKD patients were
analyzed. RESULTS: Lives saved (%) in the treatment of CKD without CPE: CKD
stage 4, 78.57; CKD stage 5, 57.58. Lives saved (%) in the treatment of CKDwith CPE:
CKD stage 4, 88.89; CKD stage 5, 65.45. Cost- effectiveness ratios for stage 4 without
and with CPEs were Rp3,593,295.97 and Rp3,348,733.27, respectively. Cost-effec-
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tiveness ratios for stage 5 without and with CPEs were Rp7,870,936.19 and
Rp7,137,874.93, respectively. ICERs was Rp1,486,786.41 for CKD stage 4 and
Rp234,898.33 for CKD stage 5. CONCLUSIONS: Treatment of CKD stage 4 and 5 with
CPE was more effective and cost-effective compared to those without CPE. The
ICERs indicated that extra costs were required to increase life saved in both stages.
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OBJECTIVES: To compare health-related quality-of-life (HRQoL) in patients on hemo-
dialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) in a tertiary hos-
pital in China.METHODS: From September 2004 to January 2005, adult patients on
HD or CAPD for at least 6 months were recruited with clinical and HRQoL data
collected by medical records review and patient survey. Patients’ HRQoL was as-
sessed by KDQOL-SF including SF-36 as the generic and 11 disease-specific do-
mains with higher scores indicating better HRQoL. RESULTS: Eighty-six patients
[50 on CAPD and 36 on standard HD (3x4-hour weekly)] were included for the
analysis, with 55% male and a mean age of 57.715.6 years. No differences were
found in age, sex, education, payment method, income, originating disease, hae-
moglobin level, and dialysis time between HD and CAPD. CAPD patients had a
higher score (SD) compared to HD patients for Effects of Kidney Disease (EKD:
55.1(15.8) vs. 40.8(10.2), p .0001), Symptom/Problem List (SPL: 67.8(12.6) vs.
59.5(7.7), p 0.0005), Quality of Social Interaction (QSI: 65.0(13.9) vs. 58.1(9.1), p
0.006) and Patient Satisfaction (PS: 70.0(12.1) vs. 60.7(13.3), p0.001). CAPD group vs.
HDalsohadhigher scoresonBodyPain (BP: 60.2(14.2) vs. 45.4(18.1), p 0.0003), General
Health (GH: 33.6 (15.1) vs. 26.7(11.7), p0.03), Role-Emotional (RE: 61.4(25.5) vs.
41.7(33.2), p0.002) and Mental Health (MH: 67.3(14.0) vs. 55.3(19.4), p 0.002) from
SF-36 assessment. Controlling for key factors/covariates, CAPD patients still showed
better scores comparing toHDpatients inEKD,SPL, PS, BP,REandMH.Olderage, lower
haemoglobin level and originating disease of hypertension were shown to be associ-
ated with lower scores of certain dimensions compared to their counterparts,
respectively. CONCLUSIONS: CAPD patients showed better HRQoL in EKD, SPL,
PS, BP, RE and MH than HD patients in this study population. The findings may
help understand HRQoL burden and influential factors among dialysis patients.
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OBJECTIVES: To obtain availability and assess the quality of existing evidence on
effectiveness of poliglecaprone, polydioxanone and polyglactin-910 when used in
different abdominal layers suturing.METHODS: Studies were identified by means
of systematic search in MEDLINE, EMBASE and CENTRAL databases. Supplemen-
tary search for ongoing trials was also conducted. All studies published since 2000
and evaluating at least one of the selected interventions, with exception to case
reports and cross sectional studies, were regarded as appropriate. Data selection
was performed independently by two reviewers. Each study was characterized in
detail according to predefined categories. Quality of those trials was assessed using
Jadad or NOS scale depending on the type of the study. All information were sub-
sequently exploited to create Dynamic Literature Catalogue – a novel toll for quick
and efficient data reviewing. RESULTS: Among 119 positions qualified for full text
analysis 40 publications met our inclusion criteria. Majority of those studies (n 
30) were designed as RCTs, eight were non-randomized comparative studies, one
was conducted in a single arm scheme. Sixteen trials had their center location
situated in Asia region. Twenty-six studies were considered as large trials includ-
ing  100 patients. Target population comprised mainly adult patients. Main re-
ported outcomes were wound infection or other complications, healing and cos-
mesis effects and patients satisfaction. All data extracted from publication were
included in the Dynamic Literature Catalogue. To make reviewing of all selected
information more efficient, we categorized them into several domains distin-
guished in accordance with PICO scheme. Appropriate filters allowing for quick
data selection and analyzing were used in each domain. CONCLUSIONS: There is
numerous of available evidence on using poliglecaprone, polydioxanone and
polyglactin-910 in different abdominal layers suturing. We showed that reviewing
and analyzing this data can be simplified and adjusted to different area of interest
when Dynamic Literature Catalogue is used.
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OBJECTIVES: Although the WHO fracture risk assessment tool (FRAXTM) has been
developed, its algorithm is unpublished and not necessarily available for economic
evaluations. The purpose of this studywas to develop a health economicmodel for
assessing the cost-effectiveness of osteoporosis treatment in postmenopausal
womenwith rheumatoid arthritis, who have received combination therapy includ-
ing corticosteroids in Japan.METHODS:We constructed risk equations for age and
bone mineral density (BMD)-specific fracture applying a series of methods pro-
posed by De Laet CE et al (1997) to epidemiological data unique to Japanese. A state
transition model with six health states (no fracture, post-vertebral fracture, post-
hip fracture, post-vertebral and hip fracture, bedridden, and death) was developed
to predict a ten year probability of hip fracture and the ten year probability of a
major osteoporoetic fracture. Model validity was verified by comparison of the
predicted fracture probabilities by different combination of age (55 to 65 years) and
BMD (T-score -1.5 to -2.5) between the developed model and FRAX. RESULTS: Indi-
vidual simulation for 1,000womenaged 55, 60 and 65 years resulted in the expected
life years of 31.3 to 32.3, 27.1 to 27.9 and 22.9 to 23.6, respectively, about the same as
in national life table in Japan. The predicted probability of hip fracture in women
with T-score -1.5, -2.0 and -2.5were ranged to 0.8 to 1.4%, 1.4 to 2.5% and 2.9 to 5.1%,
respectively, and consistent with those of FRAX as follows: 0.8 to 1.9%, 1.5 to 3.1%
and 2.8 to 5.2%, respectively. As expected, our model had the tendency to slightly
underestimate the probability of a major fracture because the model did not con-
sider an occurrence of humerus fracture and wrist fracture. CONCLUSIONS: The
model newly developed was validated and helpful for determining the cost-effec-
tive treatment thresholds for corticosteroid-induced osteoporosis in postmeno-
pausal women with rheumatoid arthritis.
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OBJECTIVES: To develop standard unit costs of medical services provided by dif-
ferent health facilities, cost of patients coming for treatments, and reference values
used in the economic evaluation.METHODS: The project was conducted as a num-
ber of sub-projects. Analysis of unit cost of medical services was conducted in 5
hospitals employing the relative value unit method. Cost of health center services
was calculated in 19 health centers employing standard costing andmicro-costing
methods. Cost of pharmaceutical services was analysed in 11 hospitals. Logistics
cost of vaccines under the national vaccination program covered the supply chain
from the central supplier to provincial health offices. Cost of patients coming to
have treatments was collected by interviewing 900 patients from 6 health centers,
3 district hospitals and 3 provincial/regional hospitals. Reference values were ob-
tained from documentary research. RESULTS: The results were published in a
book, and can be accessed via the Health Intervention and Technology Assessment
(HITAP) website (http://db.hitap.net/). They are composed of 3091 items of hospital
medical services in two categories of hospitals: district and provincial/regional
hospitals. Services of hospital pharmacy departments, and health services pro-
vided by health centers, include 9 and 68 items, respectively. Logistics cost of
vaccines is presented as cost per dose of the vaccine supplied. Cost of patients is
composed of distance, time, transportation cost and meal cost. Reference values
are useful years of capital assets (i.e. buildings, vehicles, furniture and equipment),
minimumwage, and gross domestic product per capita. CONCLUSIONS: This stan-
dard cost menu and reference values should make economic evaluations faster
and more convenient. This is the first standard cost menu to be developed for
Thailand. Some limitations exist, whichwill be improved upon in the next revision.
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OBJECTIVES: Some insist that productivity loss should not be included in costs
when using quality-adjusted life year (QALY) because QALY also reflects the influ-
ence of work loss and thus results in “double counting.” “Double counting” of QALY
and productivity loss is a controversial issue, particularly given the lack of empir-
ical data addressing the influence of income reduction on utility scores.METHODS:
In this study, we performed a web-based, large-sample survey to address the issue
of double counting. To determine the influence of income reduction on utility
scores, we obtained utility scores of eight health states with three instruction
types: a) no instruction; b) instructed to consider income reduction; and c) in-
structed not to consider income reduction (compensated). Respondents were ran-
domly sampled from the on-line panel adjusted by age and sex. Theywere asked to
evaluate one of 24 patterns by both standard gamble (SG) and time trade-off (TTO)
methods. RESULTS: A total of 6551 respondents completed the questionnaire. Re-
spondent demographics were similar to the Japanese general population. First,
despite the lack of instruction on income reduction, many respondents spontane-
ously assumed lost income. The proportion tended to be higher when considering
more severe health states. Second, the degree of assumed income reduction was
related to utility scores. For a 10% income reduction, respondents assumed a 0.02 to
0.04 decrease in utility score (both SG and TTO methods). Third, utility scores did
not change significantly, even when the decrease in income was compensated. In
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